Sign in

William Jordan

Research Analyst at Tsa Wealth Managment LLC

William Jordan is a Research Analyst at TSA Investment, specializing in analyzing healthcare and biotechnology companies. He has specifically covered Orgenesis, contributing to earnings call analysis and Q&A sessions to inform investment decisions. With experience focused on fundamental research, Jordan's performance record is limited in public databases, showing involvement in at least one company coverage and participation in earnings calls. Details about previous roles, FINRA registration, or securities licenses are not currently available, but his work at TSA Investment demonstrates expertise in targeted company research within the biotech sector.

William Jordan's questions to Orgenesis (ORGS) leadership

Question · Q4 2022

William Jordan from TSA Investment asked about the impact of the significant investment from Metalmark Capital Partners on the business, specifically concerning the deployment of new OMPULs.

Answer

CEO Vered Caplan stated that the capital from Metalmark is crucial as it allows Orgenesis to execute its plans, provide necessary production capacity for customers, and grow with the industry. She highlighted that the investment validates their approach and provides the flexibility to respond quickly to capacity demands, a key differentiator from centralized models that require long-term planning.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts